Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Long-Term Deferred Tax (2020 - 2025)

MDxHealth (MDXH) has disclosed Long-Term Deferred Tax for 5 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax changed N/A to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.6 million for FY2025, N/A changed from the prior year.
  • Long-Term Deferred Tax hit $1.6 million in Q4 2025 for MDxHealth, down from $10.8 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $11.0 million in Q4 2022 to a low of $1.6 million in Q4 2025.
  • Historically, Long-Term Deferred Tax has averaged $7.7 million across 4 years, with a median of $9.0 million in 2021.
  • Biggest five-year swings in Long-Term Deferred Tax: surged 51.85% in 2022 and later dropped 2.14% in 2023.
  • Year by year, Long-Term Deferred Tax stood at $7.3 million in 2021, then soared by 51.85% to $11.0 million in 2022, then decreased by 2.14% to $10.8 million in 2023, then plummeted by 85.15% to $1.6 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for MDXH at $1.6 million in Q4 2025, $10.8 million in Q4 2023, and $11.0 million in Q4 2022.